Cell lines used in prostate cancer research: a compendium of old and new lines--part 2.
暂无分享,去创建一个
[1] J. Pontes,et al. Immunochemical identification of prostatic epithelial cells in culture. , 1979, Investigative urology.
[2] C. Sawyers,et al. Development of an animal model for prostate cancer cell metastasis to adult human bone. , 2001, Anticancer research.
[3] D. Williams,et al. A human prostatic stromal myofibroblast cell line WPMY-1: a model for stromal-epithelial interactions in prostatic neoplasia. , 1999, Carcinogenesis.
[4] D. Horsfall,et al. Xenografted small cell undifferentiated cancer of prostate: Possible common origin with prostatic adenocarcinoma , 1988, The Prostate.
[5] C. Korch,et al. TSU-Pr1 and JCA-1 cells are derivatives of T24 bladder carcinoma cells and are not of prostatic origin. , 2001, Cancer research.
[6] L. Chung,et al. Androgen-repressed phenotype in human prostate cancer. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[7] G. Jenster,et al. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. , 1990, Biochemical and biophysical research communications.
[8] U. Stenram,et al. Differential expression of uPA in an aggressive (DU 145) and a nonaggressive (1013L) human prostate cancer xenograft , 1995, The Prostate.
[9] M. Webber,et al. Cadmium-induced malignant transformation of human prostate epithelial cells. , 2001, Cancer research.
[10] M. Stearns,et al. Isolation and characterization of PC-3 human prostatic tumor sublines which preferentially metastasize to select organs in S.C.I.D. mice. , 1991, Differentiation; research in biological diversity.
[11] L. Chung,et al. Stromal-epithelial interactions in sex differentiation. , 1980, Biology of reproduction.
[12] Ming-Shyue Lee,et al. ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells , 2003, Oncogene.
[13] F. Claas,et al. Expression of HLA-like structures on a permanent human tumor line PC-93. , 2008, Tissue antigens.
[14] Kaighn Me. Human prostatic epithelial cell culture models. , 1980 .
[15] J. M. Blumberg,et al. Variations in morphology of urinary bladder epithelium, special reference to cystitis glandularis and carcinomas. , 1952, The Journal of urology.
[16] R. Kushima,et al. Establishment and characterization of a prostatic small‐cell carcinoma cell line (PSK‐1) derived from a patient with Klinefelter syndrome , 2000, The Prostate.
[17] T. Meng,et al. Tyrosine phosphorylation of a 185 kDa phosphoprotein (pp185) inversely correlates with the cellular activity of human prostatic acid phosphatase. , 1996, Biochemical and biophysical research communications.
[18] A. Belldegrun,et al. Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process. , 1999, Cancer research.
[19] C. Jackson-Cook,et al. Tumorigenicity of SV40 T antigen immortalized human prostate epithelial cells: Association with decreased epidermal growth factor receptor (EGFR) expression , 1994, International journal of cancer.
[20] W. Birchmeier,et al. Hepatocyte growth factor/scatter factor induces a variety of tissue- specific morphogenic programs in epithelial cells , 1995, The Journal of cell biology.
[21] S. Schwartz,et al. A new human prostate carcinoma cell line, 22Rv1 , 1999, In Vitro Cellular & Developmental Biology - Animal.
[22] R. Hubert,et al. STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[23] P. Weijerman,et al. Expression of prostatic factors measured by reverse transcription polymerase chain reaction in human papillomavirus type 18 deoxyribonucleic acid immortalized prostate cell lines. , 1998, Urology.
[24] K. Pienta,et al. Establishment and characterization of a new human prostatic cancer cell line: DuCaP. , 2001, In vivo.
[25] K. Nakashiro,et al. Androgen receptor expression in androgen‐independent prostate cancer cell lines , 2001, The Prostate.
[26] F. Meyers,et al. Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] R. K. Bright,et al. Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens. , 1997, Cancer research.
[28] I. Leav,et al. Adenocarcinoma of the canine prostate , 1968, Cancer.
[29] T. Chen,et al. Chromosome identity of human prostate cancer cell lines, PC-3 and PPC-1. , 1993, Cytogenetics and cell genetics.
[30] D. Peehl,et al. Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a. , 1999, The Journal of urology.
[31] D. Paulson,et al. Establishment of a long‐term adenocarcinoma of the prostate cell line in the nude mouse , 1985 .
[32] R. Ostenson,et al. Human primary prostate tumor cell line, ALVA‐31: A new model for studying the hormonal regulation of prostate tumor cell growth , 1993, The Prostate.
[33] L. Chung,et al. LNCaP progression model of human prostate cancer: Androgen‐independence and osseous metastasis , 2000, The Prostate.
[34] P. Hermanek,et al. Human prostatic adenocarcinoma: Some characteristics of a serially transplantable line in nude mice (PC 82) , 1980, The Prostate.
[35] J. Gingrich,et al. Establishment and characterization of a new human prostatic carcinoma cell line (DuPro-1). , 1991, The Journal of urology.
[36] S. Hayward,et al. Malignant transformation in a nontumorigenic human prostatic epithelial cell line. , 2001, Cancer research.
[37] M. Gleave,et al. Derivation of androgen‐independent human LNCaP prostatic cancer cell sublines: Role of bone stromal cells , 1994, International journal of cancer.
[38] M. Fullerton,et al. Ectopic hormone production by a prostatic small cell carcinoma xenograft line , 1988, Molecular and Cellular Endocrinology.
[39] I. Kondo,et al. Establishment of a new prostatic carcinoma cell line (TSU-Pr1). , 1987, The Journal of urology.
[40] Christopher J. Logothetis,et al. Model Systems of Prostate Cancer: Uses and Limitations , 1998, Cancer and Metastasis Reviews.
[41] B. Dutrillaux,et al. Clinical and experimental progression of a new model of human prostate cancer and therapeutic approach. , 2001, The American journal of pathology.
[42] E. Wills,et al. Site‐specific growth of the prostate xenograft line UCRU‐PR‐2 , 1989, The Prostate.
[43] E. Hoal-van Helden,et al. Detection by DNA fingerprinting of somatic changes during the establishment of a new prostate cell line. , 1994, British Journal of Cancer.
[44] A. Belldegrun,et al. WISH-PC2: a unique xenograft model of human prostatic small cell carcinoma. , 2000, Cancer research.
[45] K. Pienta,et al. VCaP, a cell-based model system of human prostate cancer. , 2001, In vivo.
[46] L. Chung,et al. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. , 1994, Cancer research.
[47] P. Troncoso,et al. c-met proto-oncogene expression in benign and malignant human prostate tissues. , 1995, The Journal of urology.
[48] R. Vessella,et al. Comparative genomic hybridization and molecular cytogenetic characterization of two prostate cancer xenografts , 1997, Genes, chromosomes & cancer.
[49] A. Pantuck,et al. CL1-GFP: an androgen independent metastatic tumor model for prostate cancer. , 2000, The Journal of urology.
[50] Mike Wilson,et al. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[51] S. Naylor,et al. Retention of chromosome 3 in extrapulmonary small cell cancer shown by molecular and cytogenetic studies. , 1989, Journal of the National Cancer Institute.
[52] C. Harris,et al. Transformation of human neonatal prostate epithelial cells by strontium phosphate transfection with a plasmid containing SV40 early region genes. , 1989, Cancer research.
[53] M. Yamaoka,et al. Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline. , 2003, Cancer research.
[54] M. Webber,et al. Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression , 2001, The Prostate.
[55] C. Jackson-Cook,et al. Cytogenetic characterization of the human prostate cancer cell line P69SV40T and its novel tumorigenic sublines M2182 and M15. , 1996, Cancer genetics and cytogenetics.
[56] N. Maitland,et al. In Vitro Models to Study Cellular Differentiation and Function in Human Prostate Cancers , 2001, Radiation Research.
[57] P. Nelson,et al. A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49. , 2002, The American journal of pathology.
[58] R L Vessella,et al. Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[59] F. Smedts,et al. Identification of intermediate cell types by keratin expression in the developing human prostate , 1998, The Prostate.
[60] D. Paulson,et al. Isolation of a human prostate carcinoma cell line (DU 145) , 1978, International journal of cancer.
[61] N. Hay,et al. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest. , 1998, Molecular endocrinology.
[62] W. V. van Weerden,et al. Use of nude mouse xenograft models in prostate cancer research , 2000, The Prostate.
[63] R. Sellers,et al. Cultured stromal cells: An in vitro model of prostatic mesenchymal biology , 2000, The Prostate.
[64] M. Webber,et al. Malignant transformation of human prostate epithelial cells by N-nitroso-N-methylurea. , 1997, Cancer research.
[65] W. Isaacs,et al. Prostate cancer : biology, genetics, and the new therapeutics , 2007 .
[66] D. Johnston,et al. Establishment of two human prostate cancer cell lines derived from a single bone metastasis. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[67] R. Dahiya,et al. Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1 , 2007, In Vitro Cellular & Developmental Biology - Animal.
[68] C. Korch,et al. Molecular characterization of human prostate carcinoma cell lines , 2003, The Prostate.
[69] C. Harris,et al. Strontium phosphate transfection of human cells in primary culture: stable expression of the simian virus 40 large-T-antigen gene in primary human bronchial epithelial cells , 1987, Molecular and cellular biology.
[70] B. Dave,et al. Decreased androgen-responsive growth of human prostate cancer is associated with increased genetic alterations. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[71] W. Rosner,et al. Characterization of ALVA-41 cells, a new human prostatic cancer cell line , 1994, Steroids.
[72] G. Cunha,et al. Glandular epithelial induction by embryonic mesenchyme in adult bladder epithelium of BALB/c mice. , 1980, Investigative urology.
[73] T. H. van der Kwast,et al. Development of seven new human prostate tumor xenograft models and their histopathological characterization. , 1996, The American journal of pathology.
[74] K. M. Roberson,et al. Isolation and characterization of a novel human prostatic stromal cell culture: DuK50 , 1995, In Vitro Cellular & Developmental Biology - Animal.
[75] D. Peehl,et al. Erratum: Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor (Nature Medicine (2000) 6 (703-706)) , 2000 .
[76] R. Nagle,et al. N-Cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion withStromal cells. , 1999, The American journal of pathology.
[77] C. Korch,et al. Widely used prostate carcinoma cell lines share common origins , 2001, The Prostate.
[78] K. Nakashiro,et al. Hepatocyte growth factor secreted by prostate-derived stromal cells stimulates growth of androgen-independent human prostatic carcinoma cells. , 2000, The American journal of pathology.
[79] M. Mally,et al. Cell characterization by use of multiple genetic markers. , 1984, Advances in experimental medicine and biology.
[80] M. Resnick,et al. Xenografts of primary human prostatic carcinoma. , 1993, Journal of the National Cancer Institute.
[81] T. Tammela,et al. Human pHyde is not a classical tumor suppressor gene in prostate cancer , 2003, International journal of cancer.
[82] L. Terracio,et al. Oncogenicity of rat prostate cells transformed in vitro with cadmium chloride , 1988, Archives of Toxicology.
[83] H. Klocker,et al. DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction , 1993, The Prostate.
[84] S. Schwartz,et al. CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. , 1996, Cancer research.
[85] George L. Wright,et al. Phenotypic and cytogenetic characterization of a cell line derived from primary prostatic carcinoma , 1989, International journal of cancer.
[86] J. Rhim,et al. Loss of response to epidermal growth factor and retinoic acid accompanies the transformation of human prostatic epithelial cells to tumorigenicity with v-Ki-ras. , 1997, Carcinogenesis.
[87] M. Webber,et al. Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. , 1997, Carcinogenesis.
[88] D. Williams,et al. Prostate specific antigen and androgen receptor induction and characterization of an immortalized adult human prostatic epithelial cell line. , 1996, Carcinogenesis.
[89] G. Murphy,et al. LNCaP model of human prostatic carcinoma. , 1983, Cancer research.
[90] P. Hein,et al. Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium , 2000, Breast Cancer Research.
[91] C. Tepper,et al. Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line. , 2002, Cancer research.
[92] P. Ye,et al. Androgen receptor up-regulates insulin-like growth factor binding protein-5 (IGFBP-5) expression in a human prostate cancer xenograft. , 1999, Endocrinology.
[93] L. Ossowski,et al. Activation of Rb and decline in androgen receptor protein precede retinoic acid–induced apoptosis in androgen‐dependent LNCaP cells and their androgen‐independent derivative , 1999, Journal of cellular physiology.
[94] P. Hermanek,et al. Prostatic adenocarcinoma PC EW, a new human tumor line transplantable in nude mice , 1984, The Prostate.
[95] E. Kruse,et al. Identification by C‐banding of two human prostate tumour cell lines, 1013L and DU 145 , 1989, International journal of cancer.
[96] H. Grossman,et al. UM-SCP-1, a new human cell line derived from a prostatic squamous cell carcinoma. , 1984, Cancer research.
[97] G. Miller,et al. Karyotypic similarity identified by multiplex‐FISH relates four prostate adenocarcinoma cell lines: PC‐3, PPC‐1, ALVA‐31, and ALVA‐41 , 2001, Genes, chromosomes & cancer.
[98] M. Lucia,et al. Spectral karyotype (SKY) analysis of human prostate carcinoma cell lines , 2003, The Prostate.
[99] J. Pontes,et al. MA 160 and EB 33 cell lines: HeLa cell contaminants, hybrids or prostatic epithelial cells? , 1979, In Vitro.
[100] J. McNeal,et al. Differential cytokeratin expression in normal, hyperplastic and malignant epithelial cells from human prostate. , 1990, The Journal of urology.
[101] P. Weijerman,et al. Characterization of adult human prostatic epithelial-cells immortalized by polybrene-induced DNA transfection with a plasmid containing an origin-defective sv40-genome. , 1994, International journal of oncology.
[102] A. Cress,et al. PEAZ‐1: A new human prostate neoplastic epithelial cell line , 2001, The Prostate.
[103] F. Schröder,et al. Human prostatic carcinoma in cell culture: Preliminary report on the development and characterization of an epithelial cell line (EB 33) , 1974, Urological Research.
[104] A. Vannier,et al. IPM‐FISH, a new M‐FISH approach using IRS‐PCR painting probes: Application to the analysis of seven human prostate cell lines , 2001, Genes, chromosomes & cancer.
[105] J. Rhim. In vitro human cell culture models for the study of prostate cancer , 2000, Prostate Cancer and Prostatic Diseases.
[106] S. Schwartz,et al. CWR22: androgen-dependent xenograft model derived from a primary human prostatic carcinoma. , 1994, Cancer research.
[107] L. Liotta,et al. Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia. , 1995, Cancer research.
[108] K. Münger,et al. Stabilization and functional impairment of the tumor suppressor p53 by the human papillomavirus type 16 E7 oncoprotein. , 2002, Virology.
[109] R. Dahiya,et al. Establishment and characterization of a human primary prostatic adenocarcinoma cell line (ND-1). , 1992, The Journal of urology.
[110] G. Bepler,et al. Establishment and identification of small cell lung cancer cell lines having classic and variant features. , 1985, Cancer research.
[111] K. A. Klein,et al. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice , 1997, Nature Medicine.
[112] Desok Kim,et al. Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes. , 1998, Cancer research.
[113] D. Lubaroff. HPC-36: an epithelial tissue culture line derived from human prostate adenocarcinoma. , 1978, National Cancer Institute monograph.
[114] Donna M. Peehl,et al. Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor , 2000, Nature Medicine.
[115] M. Webber,et al. Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications part I. Cell markers and immortalized nontumorigenic cell lines , 1996, The Prostate.
[116] S. Naito,et al. Antiproliferative Effect of Calcitriol on Human Prostatic Cancer Cell Lines: Unrelated to the Expression of Major Histocompatibility Complex Antigens or Intercellular Adhesion Molecule‐1 (ICAM‐1) , 1998, International journal of urology : official journal of the Japanese Urological Association.
[117] F. Bladou,et al. A Nod Scid mouse model to study human prostate cancer , 2002, Prostate Cancer and Prostatic Diseases.
[118] P. Weijerman,et al. Lipofection-mediated immortalization of human prostatic epithelial cells of normal and malignant origin using human papillomavirus type 18 DNA. , 1994, Cancer research.
[119] C. Sawyers,et al. Xenograft Models and the Molecular Biology of Human Prostate Cancer , 2001 .
[120] T. McDonnell,et al. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer. , 2000, Clinical Cancer Research.
[121] I. Fidler,et al. Metastatic behavior of human tumor cell lines grown in the nude mouse. , 1984, Cancer research.
[122] J. Rhim,et al. Neoplastic transformation of a human prostate epithelial cell line by the v‐Ki‐ras oncogene , 1993, The Prostate.
[123] J. Lechner,et al. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). , 1979, Investigative urology.
[124] C. Larsson,et al. 5q11, 8p11, and 10q22 are recurrent chromosomal breakpoints in prostate cancer cell lines , 2001, Genes, chromosomes & cancer.
[125] R. Ostenson,et al. Effects of sex hormone binding globulin (SHBG) on human prostatic carcinoma , 1991, The Journal of Steroid Biochemistry and Molecular Biology.
[126] D. Paulson,et al. Spontaneous metastasis of cells of the human prostate carcinoma cell line PC-3 in athymic nude mice. , 1982, The Journal of urology.
[127] O. Cussenot,et al. Immortalization of human adult normal prostatic epithelial cells by liposomes containing large T-SV40 gene. , 1991, The Journal of urology.
[128] F. Kaye,et al. Molecular genetic characterization of neuroendocrine lung cancer cell lines. , 1995, Anticancer research.
[129] J. Rhim,et al. A novel human cancer culture model for the study of prostate cancer , 2001, Oncogene.
[130] J A Thomson,et al. Short tandem repeat profiling provides an international reference standard for human cell lines , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[131] M. Webber,et al. Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications. Part 3. Oncogenes, suppressor genes, and applications , 1997, The Prostate.
[132] S. Hayward,et al. Cell differentiation lineage in the prostate. , 2001, Differentiation; research in biological diversity.
[133] C. Kao,et al. Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate‐specific antigen‐producing tumors in athymic and SCID/bg mice using LNCaP and lineage‐derived metastatic sublines , 1998, International journal of cancer.
[134] H. Drexler,et al. Widespread intraspecies cross‐contamination of human tumor cell lines arising at source , 1999, International journal of cancer.
[135] W. Isaacs,et al. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. , 1999, Cancer research.
[136] J. Addonizio,et al. Establishment of new human prostatic cancer cell line (JCA-1). , 1990, Urology.
[137] A. Brothman,et al. Metastatic properties of the human prostatic cell line, PPC-1, in athymic nude mice. , 1991, The Journal of urology.
[138] S. Maygarden,et al. Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line , 1998, The Prostate.
[139] D. Eisenberg,et al. Heterogeneity of molecular targets on clonal cancer lines derived from a novel hormone‐refractory prostate cancer tumor system , 2003, The Prostate.
[140] M. Webber,et al. Stepwise immortalization and transformation of adult human prostate epithelial cells by a combination of HPV-18 and v-Ki-ras. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[141] Martin R. Schneider,et al. Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system , 1999, British Journal of Cancer.
[142] J. Lechner,et al. Differential properties among clones of simian virus 40-transformed human epithelial cells. , 1980, Carcinogenesis.
[143] N. Goldstein,et al. Surface-epitope masking and expression cloning identifies the human prostate carcinoma tumor antigen gene PCTA-1 a member of the galectin gene family. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[144] N. D. Reed. Proceedings of the third International Workshop on Nude Mice , 1982 .
[145] S. Arya,et al. The LNCaP cell line--a new model for studies on human prostatic carcinoma. , 1980, Progress in clinical and biological research.
[146] D. Paulson,et al. Characterization of a human prostate adenocarcinoma cell line (DU 145) as a monolayer culture and as a solid tumor in athymic mice. , 1980, Progress in clinical and biological research.
[147] R. Vollmer,et al. Heterotransplantation of a human prostatic adenocarcinoma cell line in nude mice. , 1977, Cancer research.
[148] G. Wilding,et al. Efficacy of suramin against human prostate carcinoma DU145 xenografts in nude mice , 1999, Cancer Chemotherapy and Pharmacology.
[149] M. Tsai,et al. Molecular Mechanisms of Androgen-Independent Growth of Human Prostate Cancer LNCaP-AI Cells1. , 1999, Endocrinology.
[150] P. Russell,et al. Characterization of a human, sex steroid-responsive transitional cell carcinoma maintained as a tumor line (R198) in athymic nude mice. , 1984, Cancer research.
[151] Williams Rd. Human urologic cancer cell lines. , 1980 .
[152] T. H. van der Kwast,et al. Androgen‐independent growth is induced by neuropeptides in human prostate cancer cell lines , 2000, The Prostate.
[153] R. Vessella,et al. LuCaP 35: A new model of prostate cancer progression to androgen independence , 2003, The Prostate.
[154] L. Liotta,et al. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. , 1996, Cancer research.
[155] M. Webber,et al. Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications part 2. Tumorigenic cell lines , 1997, The Prostate.
[156] J. Thrasher,et al. The effect on the insulin-like growth factor system in human prostate epithelial cells of immortalization and transformation by simian virus-40 T antigen. , 1996, The Journal of clinical endocrinology and metabolism.